Literature DB >> 24412127

Recurrence rates of ocular toxoplasmosis during pregnancy.

Arthur M D Braakenburg1, Catherine M Crespi2, Gary N Holland3, Sheng Wu2, Fei Yu4, Aniki Rothova5.   

Abstract

PURPOSE: To investigate whether recurrence rates of ocular toxoplasmosis are higher during pregnancy in women of childbearing age.
DESIGN: Retrospective longitudinal cohort study.
METHODS: We reviewed medical records of all women seen at a university eye clinic (Utrecht, Netherlands) during episodes of active toxoplasmic retinochoroiditis that occurred while the women were of childbearing age (16-42 years). Each woman was sent a questionnaire requesting information regarding all pregnancies and episodes of ocular toxoplasmosis, whether or not episodes were observed at the eye clinic. Conditional fixed-effects Poisson regression was used to model incidence rate ratios of recurrence during pregnant versus nonpregnant intervals, adjusted for potential confounders, including age at time of active toxoplasmic retinochoroiditis and interval since last episode of active disease, which are known to influence risk for recurrence.
RESULTS: Questionnaires were returned by 50 (58%) of 86 women, 34 of whom had had 69 pregnancies during 584 person-years of study. There were 128 episodes of ocular toxoplasmosis during the study period (6 during pregnancy). First episodes of ocular toxoplasmosis occurred between ages 9.6 and 38.5 years. The youngest age at pregnancy was 16.1 years; the oldest age at childbirth was 40.9 years. The incidence-rate ratios for pregnant versus nonpregnant intervals were in the direction of lower recurrence rates during pregnancy, with point estimates of 0.54 and 0.75 under 2 different approaches, but the ratios were not significantly different from the null value (P values of 0.16 and 0.55).
CONCLUSIONS: Recurrence rates of ocular toxoplasmosis are probably not higher during pregnancy, in contrast to traditional beliefs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24412127      PMCID: PMC3959617          DOI: 10.1016/j.ajo.2014.01.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  The course of uveitis in pregnancy and postpartum.

Authors:  Nathalie P Y Chiam; Anthony J H Hall; Richard J Stawell; Lucy Busija; Lyndell L P Lim
Journal:  Br J Ophthalmol       Date:  2013-07-25       Impact factor: 4.638

Review 2.  A review of the changes in the ophthalmic and visual system in pregnancy.

Authors:  Afekhide E Omoti; Joseph M Waziri-Erameh; Valentina W Okeigbemen
Journal:  Afr J Reprod Health       Date:  2008-12

3.  Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

Authors:  Lotje E H Bosch-Driessen; Tos T J M Berendschot; Jenny V Ongkosuwito; Aniki Rothova
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

4.  Reactivation of human herpesvirus 6 during pregnancy.

Authors:  H Dahl; G Fjaertoft; T Norsted; F Z Wang; M Mousavi-Jazi; A Linde
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  Noninfectious uveitis and pregnancy.

Authors:  Peter K Rabiah; Albert T Vitale
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

6.  Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis.

Authors:  Gary N Holland; Catherine M Crespi; Ninette ten Dam-van Loon; Alexander C Charonis; Fei Yu; Lotje H Bosch-Driessen; Aniki Rothova
Journal:  Am J Ophthalmol       Date:  2008-03-17       Impact factor: 5.258

7.  An update on current practices in the management of ocular toxoplasmosis.

Authors:  Gary N Holland; Kevan G Lewis
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

8.  Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

9.  Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

Review 10.  Emerging infections and pregnancy.

Authors:  Denise J Jamieson; Regan N Theiler; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

View more
  4 in total

1.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

Review 2.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

3.  Management of toxoplasmic retinochoroiditis during pregnancy, postpartum period and lactation: clinical observations.

Authors:  Joanna Brydak-Godowska; Joanna Moneta-Wielgoś; Dariusz Kęcik; Piotr Karol Borkowski
Journal:  Med Sci Monit       Date:  2015-02-25

4.  Do pregnancy, postpartum period and lactation predispose to recurrent toxoplasmic retinochoroiditis?

Authors:  Joanna Brydak-Godowska; Piotr Karol Borkowski; Daniel Rabczenko; Joanna Moneta-Wielgoś; Dariusz Kęcik
Journal:  Med Sci Monit       Date:  2015-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.